Historic Bull Market Continues Amid Risk Signals
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Yahoo Finance
- Market Resilience: Despite the ongoing war in Iran and rising inflation, both the S&P 500 and Nasdaq Composite continue to trade near all-time highs, indicating strong market resilience and investor confidence, which may attract more capital into equities.
- Interest Rate Policy Impact: Under new Fed Chairman Kevin Warsh, the potential for asset sales or halting bond purchases could lead to rising yields, posing greater pressure on the stock market, especially given the current high valuations.
- Equity Risk Premium Warning: With the S&P 500's P/E ratio around 22 and 10-year Treasury yields at 4.45%, the equity risk premium is close to zero, signaling potential market risks that investors should be cautious of moving forward.
- Optimistic Earnings Growth Outlook: Despite high valuation risks, analysts project S&P 500 earnings growth of 23.2% for 2026 and 16.2% for 2027, significantly above historical averages, reflecting a bullish sentiment regarding future profitability in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NVDA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NVDA
Wall Street analysts forecast NVDA stock price to rise
41 Analyst Rating
39 Buy
1 Hold
1 Sell
Strong Buy
Current: 207.410
Low
200.00
Averages
264.97
High
352.00
Current: 207.410
Low
200.00
Averages
264.97
High
352.00
About NVDA
NVIDIA Corporation is an artificial intelligence (AI) infrastructure company. The Company is engaged in accelerated computing to help solve the challenging computational problems. Its segments include Compute & Networking and Graphics. The Compute & Networking segment includes its Data Center accelerated computing and networking platforms and AI solutions and software, and automotive platforms and autonomous and electric vehicle solutions, including software. The Graphics segment includes GeForce GPUs for gaming and personal computers (PCs), and Quadro/NVIDIA RTX GPUs for enterprise workstation graphics. Its technology stack includes the foundational NVIDIA CUDA development platform that runs on all NVIDIA GPUs, as well as hundreds of domain-specific software libraries, frameworks, algorithms, software development kits (SDKs), and application programming interfaces (APIs). Its platforms address four markets, which include Data Center, Gaming, Professional Visualization, and Automotive.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nvidia's AI-Driven Growth Surges Significantly
- Stellar Financial Performance: Nvidia achieved a staggering 1,250% revenue increase and a 4,000% net income surge in 2023, driving a 1,320% rise in stock price, showcasing the company's robust performance and market dominance in AI.
- Data Center Growth: The company commands an 85% to 92% share of the data center GPU market, with global spending expected to reach $7 trillion by 2030, further solidifying Nvidia's leadership position in this booming sector.
- Optimistic Future Outlook: CEO Jensen Huang stated that Nvidia has visibility into $500 billion in sales over the next two years, with expectations to exceed $1 trillion in revenue by 2027, indicating strong growth potential ahead.
- Accelerated R&D Cycle: By shortening its GPU update cycle to 12-18 months compared to competitors' 3-5 years, Nvidia enhances its competitive edge in AI, with projections suggesting a market cap of $20 trillion by 2030.
See More
Nvidia Plans to Raise $20 Billion in Debt Market
- Large Financing Plan: Nvidia is planning to raise approximately $20 billion through the debt market, indicating the company's confidence in future growth and potentially supporting its expansion in AI and data center sectors.
- Positive Market Reaction: Nvidia's stock showed stability during afternoon trading on June 15, 2026, suggesting investor approval of the financing plan, which may further drive stock price appreciation.
- Diverse Use of Funds: The proceeds from this financing are expected to be allocated towards R&D, acquisitions, and infrastructure investments, aimed at strengthening the company's position in the competitive semiconductor market and enhancing long-term profitability.
- Strategic Implications: By raising funds, Nvidia can accelerate technological innovation and maintain a competitive edge in a rapidly changing market environment, further solidifying its market share in AI and high-performance computing.
See More
Three Stocks Thriving Amid Economic Headwinds
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine, mRNA-1010, aimed at addressing the low effectiveness of current flu vaccines, particularly for the elderly, which could significantly enhance its competitive position in the vaccine market.
- Krystal Biotech Strong Performance: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek, and as it expands into new markets in Europe, its revenue is expected to continue growing, showcasing its strong potential in the biotech sector.
- AMD Market Share Growth: AMD's stock has surged 129% year-to-date, with its desktop CPU market share rising to 33.2% and achieving a record 46.2% revenue share, indicating its strong competitive edge and pricing power in the AI sector.
- AI Market Opportunities: With the rise of agentic AI systems, AMD's EPYC processors are positioned as leaders in the server CPU market, potentially benefiting from a $200 billion market opportunity, further solidifying its industry standing.
See More
Investment Outlook for Moderna, Krystal Biotech, and AMD
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which addresses a critical need for effective vaccines among the elderly, potentially enhancing the company's market position and financial performance significantly.
- Krystal Biotech Growth Potential: Krystal Biotech has achieved 11 consecutive quarters of earnings growth with its gene therapy Vyjuvek for a rare disease, and it still has a large addressable market to explore, with upcoming clinical data likely to further boost its stock price.
- AMD Market Leadership: AMD's stock has soared 129% year-to-date, and its leadership in the server CPU market positions it well to capitalize on the rapidly growing artificial intelligence sector, which is expected to continue driving revenue and market share growth.
- Economic and Market Performance: Despite economic and geopolitical challenges, the S&P 500 has risen 8% so far this year, demonstrating overall market resilience, with standout performances from companies like Moderna, Krystal Biotech, and AMD, making them attractive investment options.
See More
Three Stocks Outperforming the Market
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which could significantly improve health outcomes for elderly patients and meet the urgent market need for effective vaccines, potentially leading to stronger financial performance over the next two years.
- Krystal Biotech Growth Momentum: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek for a rare disease, and it is expected to continue expanding its market presence while launching more clinical trial candidates, driving sustained revenue growth.
- AMD Market Leadership: AMD's stock has surged 129% year-to-date, with its desktop CPU market share reaching 33.2% and a record revenue share of 46.2%, showcasing its strong competitive position in the rapidly growing artificial intelligence sector.
- Optimistic Investment Outlook: Despite significant stock price increases for Moderna, Krystal Biotech, and AMD, they are still viewed as worthwhile investments, with potential for higher returns in the future, particularly against the backdrop of ongoing innovation and market expansion in their respective fields.
See More
Apple Partners with Intel for U.S. Chip Production
- Deal Announcement: President Trump revealed on social media that Apple has reached a preliminary agreement with Intel to collaboratively design and manufacture chips, marking a significant milestone after over a year of discussions.
- Manufacturing Diversification: This partnership will aid Apple in diversifying its manufacturing base, reducing reliance on TSMC, whose advanced production lines are in high demand from AI chipmakers like Nvidia and AMD.
- Increased Chip Capacity: By collaborating with Intel, Apple is expected to enhance its chip capacity to meet the growing market demand, particularly in the AI and high-performance computing sectors.
- Strengthened Market Position: This move not only bolsters Apple's competitiveness in chip manufacturing but also potentially provides stronger technical support for future product innovations, further solidifying its market position.
See More
Nvidia's AI-Driven Growth Surges Significantly
- Stellar Financial Performance: Nvidia achieved a staggering 1,250% revenue increase and a 4,000% net income surge in 2023, driving a 1,320% rise in stock price, showcasing the company's robust performance and market dominance in AI.
- Data Center Growth: The company commands an 85% to 92% share of the data center GPU market, with global spending expected to reach $7 trillion by 2030, further solidifying Nvidia's leadership position in this booming sector.
- Optimistic Future Outlook: CEO Jensen Huang stated that Nvidia has visibility into $500 billion in sales over the next two years, with expectations to exceed $1 trillion in revenue by 2027, indicating strong growth potential ahead.
- Accelerated R&D Cycle: By shortening its GPU update cycle to 12-18 months compared to competitors' 3-5 years, Nvidia enhances its competitive edge in AI, with projections suggesting a market cap of $20 trillion by 2030.
See More
Nvidia Plans to Raise $20 Billion in Debt Market
- Large Financing Plan: Nvidia is planning to raise approximately $20 billion through the debt market, indicating the company's confidence in future growth and potentially supporting its expansion in AI and data center sectors.
- Positive Market Reaction: Nvidia's stock showed stability during afternoon trading on June 15, 2026, suggesting investor approval of the financing plan, which may further drive stock price appreciation.
- Diverse Use of Funds: The proceeds from this financing are expected to be allocated towards R&D, acquisitions, and infrastructure investments, aimed at strengthening the company's position in the competitive semiconductor market and enhancing long-term profitability.
- Strategic Implications: By raising funds, Nvidia can accelerate technological innovation and maintain a competitive edge in a rapidly changing market environment, further solidifying its market share in AI and high-performance computing.
See More
Three Stocks Thriving Amid Economic Headwinds
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine, mRNA-1010, aimed at addressing the low effectiveness of current flu vaccines, particularly for the elderly, which could significantly enhance its competitive position in the vaccine market.
- Krystal Biotech Strong Performance: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek, and as it expands into new markets in Europe, its revenue is expected to continue growing, showcasing its strong potential in the biotech sector.
- AMD Market Share Growth: AMD's stock has surged 129% year-to-date, with its desktop CPU market share rising to 33.2% and achieving a record 46.2% revenue share, indicating its strong competitive edge and pricing power in the AI sector.
- AI Market Opportunities: With the rise of agentic AI systems, AMD's EPYC processors are positioned as leaders in the server CPU market, potentially benefiting from a $200 billion market opportunity, further solidifying its industry standing.
See More
Investment Outlook for Moderna, Krystal Biotech, and AMD
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which addresses a critical need for effective vaccines among the elderly, potentially enhancing the company's market position and financial performance significantly.
- Krystal Biotech Growth Potential: Krystal Biotech has achieved 11 consecutive quarters of earnings growth with its gene therapy Vyjuvek for a rare disease, and it still has a large addressable market to explore, with upcoming clinical data likely to further boost its stock price.
- AMD Market Leadership: AMD's stock has soared 129% year-to-date, and its leadership in the server CPU market positions it well to capitalize on the rapidly growing artificial intelligence sector, which is expected to continue driving revenue and market share growth.
- Economic and Market Performance: Despite economic and geopolitical challenges, the S&P 500 has risen 8% so far this year, demonstrating overall market resilience, with standout performances from companies like Moderna, Krystal Biotech, and AMD, making them attractive investment options.
See More
Three Stocks Outperforming the Market
- Moderna Vaccine Progress: Moderna is nearing approval for its influenza vaccine mRNA-1010, which could significantly improve health outcomes for elderly patients and meet the urgent market need for effective vaccines, potentially leading to stronger financial performance over the next two years.
- Krystal Biotech Growth Momentum: Krystal Biotech has achieved positive earnings for 11 consecutive quarters with its gene therapy Vyjuvek for a rare disease, and it is expected to continue expanding its market presence while launching more clinical trial candidates, driving sustained revenue growth.
- AMD Market Leadership: AMD's stock has surged 129% year-to-date, with its desktop CPU market share reaching 33.2% and a record revenue share of 46.2%, showcasing its strong competitive position in the rapidly growing artificial intelligence sector.
- Optimistic Investment Outlook: Despite significant stock price increases for Moderna, Krystal Biotech, and AMD, they are still viewed as worthwhile investments, with potential for higher returns in the future, particularly against the backdrop of ongoing innovation and market expansion in their respective fields.
See More
Apple Partners with Intel for U.S. Chip Production
- Deal Announcement: President Trump revealed on social media that Apple has reached a preliminary agreement with Intel to collaboratively design and manufacture chips, marking a significant milestone after over a year of discussions.
- Manufacturing Diversification: This partnership will aid Apple in diversifying its manufacturing base, reducing reliance on TSMC, whose advanced production lines are in high demand from AI chipmakers like Nvidia and AMD.
- Increased Chip Capacity: By collaborating with Intel, Apple is expected to enhance its chip capacity to meet the growing market demand, particularly in the AI and high-performance computing sectors.
- Strengthened Market Position: This move not only bolsters Apple's competitiveness in chip manufacturing but also potentially provides stronger technical support for future product innovations, further solidifying its market position.
See More
